Anergis SA - Company & Market Research Reports

Anergis SA is a clinical-stage biopharmaceutical company that develops allergy vaccines based on the technology of Contiguous Overlapping Peptides for ultra-fast desensitization. It offers vaccines against birch pollen, ragweed pollen, and house dust mite allergies. Anergis SA was founded in 2001 and is based in Lausanne, Switzerland.

Global Allergy Immunotherapy Market Analysis & Trends - Product Type , Application - Forecast to 2025 - Product Thumbnail Image

Global Allergy Immunotherapy Market Analysis & Trends - Product Type , Application - Forecast to 2025

  • Report
  • 170 Pages
From
Global Allergy Rhinitis Drugs Market 2017-2021 - Product Thumbnail Image

Global Allergy Rhinitis Drugs Market 2017-2021

  • Report
  • 70 Pages
From
Allergic Rhino-Conjunctivitis - Pipeline Review, H1 2015 - Product Thumbnail Image

Allergic Rhino-Conjunctivitis - Pipeline Review, H1 2015

  • Drug Pipelines
  • 85 Pages
From
Global Allergy Immunotherapies Market 2016-2020 - Product Thumbnail Image

Global Allergy Immunotherapies Market 2016-2020

  • Report
  • 87 Pages
From
Birch Pollen Allergy - Pipeline Insight, 2018 - Product Thumbnail Image

Birch Pollen Allergy - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Global Allergic Rhinitis Drugs Market 2016-2020 - Product Thumbnail Image

Global Allergic Rhinitis Drugs Market 2016-2020

  • Report
  • 90 Pages
From
Ragweed Pollen Allergy - Pipeline Review, H2 2018 - Product Thumbnail Image

Ragweed Pollen Allergy - Pipeline Review, H2 2018

  • Drug Pipelines
  • 36 Pages
From
House Dust Mite Allergy - Pipeline Review, H2 2018 - Product Thumbnail Image

House Dust Mite Allergy - Pipeline Review, H2 2018

  • Drug Pipelines
  • 51 Pages
From
Birch Pollen Allergy - Pipeline Review, H2 2018 - Product Thumbnail Image

Birch Pollen Allergy - Pipeline Review, H2 2018

  • Drug Pipelines
  • 45 Pages
From
Ragweed Pollen Allergy - Pipeline Review, H1 2018 - Product Thumbnail Image

Ragweed Pollen Allergy - Pipeline Review, H1 2018

  • Drug Pipelines
  • 33 Pages
From
Ragweed Allergy - Pipeline Review, H2 2016 - Product Thumbnail Image

Ragweed Allergy - Pipeline Review, H2 2016

  • Drug Pipelines
  • 37 Pages
From
Ragweed Allergy - Pipeline Review, H1 2016 - Product Thumbnail Image

Ragweed Allergy - Pipeline Review, H1 2016

  • Drug Pipelines
  • 41 Pages
From
Pollen Allergy - Pipeline Review, H2 2015 - Product Thumbnail Image

Pollen Allergy - Pipeline Review, H2 2015

  • Drug Pipelines
  • 106 Pages
From
Pollen Allergy - Pipeline Review, H1 2015 - Product Thumbnail Image

Pollen Allergy - Pipeline Review, H1 2015

  • Drug Pipelines
  • 103 Pages
From
Hypersensitivity - Pipeline Review, H2 2016 - Product Thumbnail Image

Hypersensitivity - Pipeline Review, H2 2016

  • Drug Pipelines
  • 313 Pages
From
Pollen Allergy Global Clinical Trials Review, H1, 2018 - Product Thumbnail Image

Pollen Allergy Global Clinical Trials Review, H1, 2018

  • Clinical Trials
  • 216 Pages
From
Birch Pollen Allergy Global Clinical Trials Review, H1, 2017 - Product Thumbnail Image

Birch Pollen Allergy Global Clinical Trials Review, H1, 2017

  • Clinical Trials
  • 68 Pages
From
Active Immunization for Unconventional Indications Report - Product Thumbnail Image

Active Immunization for Unconventional Indications Report

  • Report
  • 166 Pages
From
Anergis SA Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis - Product Thumbnail Image

Anergis SA Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

  • Company Profile
  • 30 Pages
From
  • 19 Results (Page 1 of 1)
Loading Indicator
adroll